Sassicaia Capital Advisers LLC Mustang Bio, Inc. Transaction History

Sassicaia Capital Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.32 - $8.27 $768 - $19,848	2,400 Added 12.9%	21,000 $8,000
Q3 2022 Nov 14, 2022	BUY	$0.46 - $7.2 $920 - $14,400	2,000 Added 12.05%	18,600 $9,000
Q2 2022 Aug 15, 2022	BUY	$0.58 - $1.13 $2,668 - $5,197	4,600 Added 38.33%	16,600 $10,000
Q1 2022 May 13, 2022	SELL	$0.73 - $1.81 $2,555 - $6,335	-3,500 Reduced 22.58%	12,000 $12,000
Q4 2021 Feb 14, 2022	BUY	$1.66 - $2.64 $25,730 - $40,920	15,500 New	15,500 $26,000
Q3 2021 Nov 15, 2021	SELL	$2.58 - $3.36 $46,440 - $60,480	-18,000 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$2.7 - $3.81 $48,600 - $68,580	18,000 New	18,000 $60,000
Q1 2021 May 17, 2021	SELL	$3.02 - $5.16 $34,126 - $58,308	-11,300 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$2.66 - $4.18 $30,058 - $47,234	11,300 New	11,300 $43,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $27.4M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Sassicaia Capital Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Sassicaia Capital Advisers LLC with notifications on news.